These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 38779660)

  • 1. Mesenchymal stem cells-macrophages crosstalk and myeloid malignancy.
    Li K; Nie H; Jin R; Wu X
    Front Immunol; 2024; 15():1397005. PubMed ID: 38779660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of tumor-associated macrophages in hematological malignancies.
    Komohara Y; Niino D; Ohnishi K; Ohshima K; Takeya M
    Pathol Int; 2015 Apr; 65(4):170-6. PubMed ID: 25707506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage crosstalk and therapies: Between tumor cells and immune cells.
    Fan CY; Zheng JS; Hong LL; Ling ZQ
    Int Immunopharmacol; 2024 Nov; 141():113037. PubMed ID: 39213868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Associated Macrophages in Hematologic Malignancies: New Insights and Targeted Therapies.
    Petty AJ; Yang Y
    Cells; 2019 Nov; 8(12):. PubMed ID: 31783588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk Between Macrophages and Breast Cancer Cells: Networking Within Tumors.
    Melwani PK; Checker R; Balla MMS; Pandey BN
    Results Probl Cell Differ; 2024; 74():213-238. PubMed ID: 39406907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages and cancer stem cells: a malevolent alliance.
    Allavena P; Digifico E; Belgiovine C
    Mol Med; 2021 Sep; 27(1):121. PubMed ID: 34583655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
    Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
    J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
    Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
    J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNAs act as modulators of macrophages within the tumor microenvironment.
    Li K; Xie T; Li Y; Huang X
    Carcinogenesis; 2024 Jun; 45(6):363-377. PubMed ID: 38459912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal Stem Cell Administration Attenuates Colon Cancer Progression by Modulating the Immune Component within the Colorectal Tumor Microenvironment.
    François S; Usunier B; Forgue-Lafitte ME; L'Homme B; Benderitter M; Douay L; Gorin NC; Larsen AK; Chapel A
    Stem Cells Transl Med; 2019 Mar; 8(3):285-300. PubMed ID: 30451398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage-based cancer immunotherapy: Challenges and opportunities.
    Bai H; Feng L; Schmid F
    Exp Cell Res; 2024 Sep; 442(1):114198. PubMed ID: 39103071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Associated Macrophages as Multifaceted Regulators of Breast Tumor Growth.
    Munir MT; Kay MK; Kang MH; Rahman MM; Al-Harrasi A; Choudhury M; Moustaid-Moussa N; Hussain F; Rahman SM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose Metabolism: The Metabolic Signature of Tumor Associated Macrophage.
    Zhang Q; Wang J; Yadav DK; Bai X; Liang T
    Front Immunol; 2021; 12():702580. PubMed ID: 34267763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated macrophages: The key player in hepatoblastoma microenvironment and the promising therapeutic target.
    Adawy A; Komohara Y; Hibi T
    Microbiol Immunol; 2024 Aug; 68(8):249-253. PubMed ID: 38923004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting immune checkpoints in hematological malignancies.
    Salik B; Smyth MJ; Nakamura K
    J Hematol Oncol; 2020 Aug; 13(1):111. PubMed ID: 32787882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review).
    Su P; Li O; Ke K; Jiang Z; Wu J; Wang Y; Mou Y; Jin W
    Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38695252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential therapeutic targets in myeloid cell therapy for overcoming chemoresistance and immune suppression in gastrointestinal tumors.
    Fan J; Zhu J; Zhu H; Xu H
    Crit Rev Oncol Hematol; 2024 Jun; 198():104362. PubMed ID: 38614267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs.
    Cresswell GM; Wang B; Kischuk EM; Broman MM; Alfar RA; Vickman RE; Dimitrov DS; Kularatne SA; Sundaram CP; Singhal S; Eruslanov EB; Crist SA; Elzey BD; Ratliff TL; Low PS
    Cancer Res; 2021 Feb; 81(3):671-684. PubMed ID: 33203700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity.
    Harrell CR; Volarevic A; Djonov VG; Jovicic N; Volarevic V
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to reprogram anti-inflammatory macrophages towards pro-inflammatory macrophages to support cancer immunotherapies.
    Vizcaino Castro A; Daemen T; Oyarce C
    Immunol Lett; 2024 Jun; 267():106864. PubMed ID: 38705481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.